rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2 Suppl 1
|
pubmed:dateCreated |
2001-8-14
|
pubmed:abstractText |
The frequency of osteoporotic fractures is greatly increased in men receiving androgen deprivation therapy (ADT), but whether the risk of osteoporosis differs between different types of ADT or between continuous and intermittent therapy has not been determined. Techniques for modifying ADT-associated bone loss have not been clearly identified.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1527-9995
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
58
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
101-7
|
pubmed:dateRevised |
2005-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11502461-Androgen Antagonists,
pubmed-meshheading:11502461-Antineoplastic Agents, Hormonal,
pubmed-meshheading:11502461-Bone Density,
pubmed-meshheading:11502461-Fractures, Bone,
pubmed-meshheading:11502461-Humans,
pubmed-meshheading:11502461-Male,
pubmed-meshheading:11502461-Osteoporosis,
pubmed-meshheading:11502461-Prostatic Neoplasms,
pubmed-meshheading:11502461-Risk Factors
|
pubmed:year |
2001
|
pubmed:articleTitle |
Osteoporosis due to androgen deprivation therapy in men with prostate cancer.
|
pubmed:affiliation |
Department of Family Practice, University of California School of Medicine at Davis, California, USA.
|
pubmed:publicationType |
Journal Article,
Review
|